作者: Qi Han , Ruinan Wang , Chongkui Sun , Xin Jin , Dongjuan Liu
DOI: 10.1371/JOURNAL.PONE.0091867
关键词:
摘要: Background Human beta-defensin-1 (hBD-1) has recently been considered as a candidate tumor suppressor in renal and prostate cancer. The aim of this study was to investigate the role hBD-1 progression oral squamous cell carcinoma (OSCC) its potential diagnostic/prognostic biomarker therapeutic target for OSCC.